Clinical outcomes of patients bilaterally implanted with the light adjustable lens: results of a phase IV clinical registry.

In 30 seconds

This multicenter prospective observational study evaluated clinical outcomes in 1101 patients bilaterally implanted with the light adjustable lens (LAL). The study found that 81.2% of eyes targeted for emmetropia achieved uncorrected distance visual acuity (UDVA) of ≥20/20, demonstrating high precision in visual outcomes regardless of prior corneal refractive surgery.

Key findings

• 81.2% of eyes targeted for emmetropia achieved UDVA of ≥20/20.
• 94.3% of eyes targeted for emmetropia had a manifest spherical equivalent of ≤0.5 diopter.
• 89% of patients with blended vision achieved binocular UDVA of ≥20/20.
• 85% of patients in the No CRS group achieved binocular uncorrected near visual acuity of ≥J1.

Why it matters

The findings highlight the effectiveness of the light adjustable lens in achieving desired visual outcomes, which is crucial for clinicians considering lens options for patients, particularly those with varying surgical histories.